Periodontitis is a major cause of adult tooth loss and is characterized by bacteria-induced inflammation and periodontal destruction. The ultimate goal of periodontal therapy is not only to slow down the development of periodontal disease, but also to regenerate the architectural and functional integrity of the periodontal complex, which includes the formation of new cementum together with a new connective tissue attachment between the newly formed bone and cementum.Periodontitis is a major cause of adult tooth loss and is characterized by bacteria-induced inflammation and periodontal destruction. The ultimate goal of periodontal therapy is not only to slow down the development of periodontal disease, but also to regenerate the architectural and functional integrity of the periodontal complex, which includes the formation of new cementum together with a new connective tissue attachment between the newly formed bone and cementum.
Wang HL, Greenwell H, FiorelliniJ. Periodontal regeneration. J Periodontol. 2005;76(9):1601-22.doi: 10.1902/jop.2005.76.9.1601.
Quinones CR, Carellas IG, Caffessee RG. Guided periodontal tissue regeneration (GPTR): an update. Pract Periodontics Aesthet Dent. 1996;8(2):169-80.
Kao RT, Conte G, Nishimine D. Tissue engineering for periodontal regeneration.J Calif Dent Assoc. 2005;33(3):205-15.
Stramazzotti D, Coiana C, ZizziA. Impactofsmokingonguidedtissueregeneration using a biocomposite poly (lactic-co-glycolic) acid/sub-micron size hydroxyapatite with a rubberdamasanalternativebarrier.Int J ImmunopatholPharmacol. 2015;28(1):21-8. doi: 10.1177/0394632015573159.
Peev S, Gusiyska A, Sabeva E. Guided bone regeneration and simultaneous implant placement. Int J SciRes(IJSR). 2016; 5(2): 1529-30.
KaoRT, NaresS, ReynoldsMA. Periodontal regeneration-intrabony defects: a systematic review from the AAP regeneration workshop. J Periodontol. 2015;86(2 Suppl):S77-104. doi: 10.1902/jop.2015.130685.
Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the treatment of intrabony defects: A controlled clinical trial.J ClinPeriodontol. 2011;38(10):925-32. doi: 10.1111/j.1600-051X.2011.01760.x.
Sculean A, Donos N, Schwarz F, Becker J, Brecx M, et al. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol. 2004;31(7):545-9.doi: 10.1111/j.1600-051X.2004.00518.x.
Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol. 2000;71(5):752-9.doi: 10.1902/jop.2000.71.5.752.
Choukroun J, Adda F, Schoeffler C. An opportunity in perio-implantology: The PRF.Implantodontie. 2001;42:55- 62.
Rana MP, Mehrotra N. Human amniotic membrane: hope in periodontal regeneration. Int JSciRes (IJSR). 2016; 5(4):564-9.
Mishra S, Singh S. Human amniotic membrane: Can it be a ray of hope in periodontal regeneration? Indian J Med Res. 2014; 3(9):118-21.
Tu Y-K, Woolston A, Faggion CM. Do bonegrafts or barrier membranes provide additional treatment efects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. J Clin Periodontol. 2010; 37(1):59-79.doi:10.1111/j.1600-051X.2009.01499.x.
Aspriello SD, Zizzi A, Spazzafumo L. Effects of enamel matrix derivative on vascular endothelial growth factor expression and microvessel density in gingival tissues of periodontal pocket: a comparative study. J Periodontol. 2011;82(4):606-12. doi: 10.1902/jop.2010.100180.
Siciliano VI, Andreuccetti G, Siciliano AI, Blasi A, Sculean A, Salvi GE.Clinicaloutcomesaftertreatmentofnon-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial. J Periodontol. 2011;82(1):62-71. doi: 10.1902/jop.2010.100144.
Crea A, Dassatti L, Hofmann O, Zafropoulos G-G, Deli G. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: A 3-year prospective randomized clinical study. J Periodontol. 2008 Dec;79(12):2281-9. doi: 10.1902/jop.2008.080135.
Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open fap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol. 2001;72(1):25-34.doi: 10.1902/jop.2001.72.1.25.
Silvestri M, Ricci G, Rasperini G. Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol. 2000;27(8):603-10.doi:10.1034/j.1600-051x.2000.027008603.x.
Hoidal MJ, Grimard BA, Mills MP, Schoolfeld JD, Mellonig JT, Mealey BL. Clinical evaluation of demineralized freeze-dried bone allograf with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol. 2008;79(12):2273-80. doi: 10.1902/jop.2008.080259.
Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograf. Int J Periodontics Restorative Dent. 2003;23(1):47-55.
Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT. A clinical comparison of a bovine-derived xenograf used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol. 2002;73(4):423-32.doi: 10.1902/jop.2002.73.4.423.
AlMachot E, Hofmann T, Lorenz K, Khalili I, Noack B.Clinical outcomes afer treatment of periodontal intrabony defects with nanocrystalline hydroxyapatite (Ostim) or enamel matrix derivatives (Emdogain): a randomized controlled clinical trial. Biomed Res Int. 2014;2014:786353. doi: 10.1155/2014/786353.
Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent. 1999;19(1):8-19.
Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol. 1997;24(9 Pt 2):693-6.
Majzoub Z, Bobbo M, Atiyeh F, Cordioli G. Two patterns of histologic healing in an intrabony defect following treatment with enamel matrix derivative: A human case report. Int J Periodontics Restorative Dent. 2005;25(3):283-94.
Sculean A, Donos N, Windisch P. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J PeriodontalRes. 1999;34(6):310-22.
Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Investig. 2002;6(3):183-7. doi: 10.1007/s00784-002-0171-6.
Sculean A, Junker R, Donos N, Windisch P, Brecx M, Dünker N. Immunohistochemical evaluation of matrix molecules associated with wound healing following treatment with an enamel matrix protein derivative in humans. Clin Oral Investig. 2003;7(3):167-74.doi: 10.1007/s00784-003-0212-9.
Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol. 1997;24(9 Pt 2):705-14.
Zetterstrom O, Andersson C, Eriksson L, Fredriksson A, Friskopp J, Heden G, et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol. 1997;24(9 Pt 2):697-704.
Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J ClinPeriodontol. 2001;28(5):397-403.
Döri F, Arweiler N, Gera I, Sculean A. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. J Periodontol. 2005;76(12):2236-43.doi: 10.1902/jop.2005.76.12.2236.
Boyan BD, Weesner TC, Lohmann CH, Andreacchio D, Carnes DL, Dean DD, et al. Porcine fetal enamel matrix derivative enhances bone formation induced by demineralised freeze dried bone allograft in vivo. J Periodontol.2000;71(8):1278-86.doi:10.1902/jop.2000.71.8.1278.
Rosen PS, Reynolds MA. A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Periodontol. 2002;73(8):942-9.doi: 10.1902/jop.2002.73.8.942.
Harrel SK, Wilson TG, Nunn ME. Prospective assessment of the use of enamel matrix proteins with minimally invasive surgery. J Periodontol. 2005;76(3):380-4.doi: 10.1902/jop.2005.76.3.380.
Velasquez-Plata D, Scheyer ET, Mellonig JT. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol. 2002;73(4):433-40.doi: 10.1902/jop.2002.73.4.433.
Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol. 2000;71(7):1110-6.doi: 10.1902/jop.2000.71.7.1110.
Gurinsky BS, Mills MP, Mellonig JT. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol. 2004;75(10):1309-18.doi: 10.1902/jop.2004.75.10.1309.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638-46.
Poorsattar Bejeh Mir A. Tissue engineering: Oromaxillofacial reconstruction with platelet rich plasma (PRP). Caspian J Dent Res. 2012;1(1):46-8.
Bashutski JD, Wang HL. Role of platelet-rich plasma in soft tissue root-coverage procedures: A review. Quintessence Int. 2008;39(6):473-83.
Dohan DM, Choukroun J, Diss A. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e37-44.doi: 10.1016/j.tripleo.2005.07.008.
Wiltfang J, Kloss FR, Kessler P, Nkenke E, Schultze-Mosgau S, Zimmermann R, et al. Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. An animal experiment. Clin Oral Implants Res. 2004;15(2):187-93.
Wiltfang J, Schlegel KA, Schultze-Mosgau S, Nkenke E, Zimmermann R, Kessler P. Sinus floor augmentation with beta-tricalciumphosphate (beta-TCP): Does platelet-rich plasma promote its osseous integration and degradation? Clin Oral Implants Res. 2003;14(2):213-8.
Velich N, Nemeth Z, Hrabak K, Suba Z, Szabo G. Repair of bony defect with combination biomaterials. J Craniofac Surg. 2004;15(1):11-5.
Dori F, Huszar T, Nikolidakis D, Tihanyi D, Horvath A, Arweiler NB, et al. Effect of platelet-rich plasma on the healing of intrabony defects treated with beta tricalcium phosphate and expanded polytetrafluoroethylene membranes. J Periodontol. 2008;79(4):660-9. doi: 10.1902/jop.2008.070473.
Kovacs K, Velich N, Huszar T, Szabo G, Semjen G, Reiczigel J, et al. Comparative study of beta-tricalcium phosphate mixed with platelet-rich plasma versus beta-tricalcium phosphate, a bone substitute material in dentistry. Acta Vet Hung. 2003;51(4):475-84.doi: 10.1556/AVet.51.2003.4.5.
Kovacs K, Velich N, Huszar T, Fenyves B, Suba Z, Szabo G. Histomorphometric and densitometric evaluation of the effects of platelet-rich plasma on the remodeling of beta-tricalcium phosphate in beagle dogs. J Craniofac Surg. 2005;16(1):150-4.
Yassibag-Berkman Z, Tuncer O, Subasioglu T, Kantarci A. Combined use of platelet-rich plasma and bone grafting with or without guided tissue regeneration in the treatment of anterior interproximal defects. J Periodontol. 2007;78(5):801-9.doi: 10.1902/jop.2007.060318.
Harnack L, Boedeker RH, Kurtulus I, Boehm S, Gonzales J, Meyle J. Use of platelet-rich plasma in periodontal surgery-A prospective randomised double blind clinical trial. Clin Oral Investig. 2009;13(2):179-87. doi: 10.1007/s00784-008-0223-7.
Döri F, Huszár T, Nikolidakis D,Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intra-bony defects treated with a natural bone mineral and a collagen membrane. J Clin Periodontol. 2007;34(3):254-61.doi: 10.1111/j.1600-051X.2006.01044.x.
Döri F, Huszár T, Nikolidakis D,Arweiler NB, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes. J Periodontol. 2007;78(6):983-90.doi: 10.1902/jop.2007.060349.
Christgau M, Moder D, Wagner J, Glässl M, Hiller KA, Wenzel A, et al. Influence of autologous platelet concentrate on healing in intrabony defects following guided tissue regeneration therapy: A randomized prospective clinical split-mouth study. J Clin Periodontol. 2006;33(12):908-21.doi: 10.1111/j.1600-051X.2006.00999.x.
Peev S, Atanasov D. Platelet-rich plasma - an accelerator of the secondary stability of immediate loaded implants. J IMAB. 2007; 13(2):38-40.
Email this article (Login required) 
